NSE - Delayed Quote INR

Alivus Life Sciences Limited (ALIVUS.NS)

1,115.60
+9.50
+(0.86%)
At close: May 9 at 3:29:56 PM GMT+5:30

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 6.42B
Earnings 1.37B

Q1'24

Q2'24

Q3'24

Q4'24

0
2B
4B
6B
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1,150.00
1,296.25 Average
1,115.60 Current
1,360.00 High

Earnings Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1--34
Avg. Estimate 10039.1749.58
Low Estimate 10038.446.9
High Estimate 10040.154.6
Year Ago EPS 7.979.0838.3839.17

Revenue Estimate

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2--34
Avg. Estimate 6.23B--24.06B28.1B
Low Estimate 6.14B--23.7B27.37B
High Estimate 6.33B--24.67B28.99B
Year Ago Sales 5.37B--22.83B24.06B
Sales Growth (year/est) 16.19%--5.38%16.81%

Earnings History

Currency in INR 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 10.491010
EPS Actual 7.979.087.7511.14
Difference -2.430.08-2.251.14
Surprise % -23.37%0.89%-22.50%11.40%

EPS Trend

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 10039.1749.58
7 Days Ago 0039.0549.24
30 Days Ago 0039.0549.35
60 Days Ago 0039.9649.43
90 Days Ago 0040.4148.62

EPS Revisions

Currency in INR Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----22
Up Last 30 Days ----22
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ALIVUS.NS 25.47%--2.05%26.57%
S&P 500 13.21%3.09%8.02%13.76%

Related Tickers